改良型中等长度导管在输注高渗液的应用研究  

Application Study of Modified Medium Length Catheter in Infusion of Hypertonic Fluid

作　　者：肖智 孙玉红[1] 张海荣[1] 戴平湖[1] 王丽[1] 胡新星 XIAO Zhi;SUN Yuhong;ZHANG Hairong;DAI Pinghu;WANG Li;HU Xinxing(Department of Neurology,Loudi Central Hospital,Loudi,Hunan Province,417000 China)

机构地区：[1]娄底市中心医院神经内科,湖南娄底417000

出　　处：《中外医疗》2022年第1期175-179,共5页China & Foreign Medical Treatment

基　　金：2020年院级科研产项课题:青年项目(Y2020—22)。

摘　　要：目的探讨改良型中等长度导管在输注高渗液的临床应用优势。方法简单随机选取该院2019年3月─2020年4月100例给予高渗液20%甘露醇和/或甘油果糖静脉输液治疗的患者,根据随机数字表法将100例患者分成留置针组(intravenous catheter for single use,IVC)和改良型中等长度导管组(midline catheters,MC),各50例,观察两组患者在导管留置期间并发症发生率。结果通过对两组导管留置期间并发症发生率进行统计对比,结果显示中等长度导管组(MC组)的静脉炎、渗出的发生率分别为0.00%、4.00%,较留置针组(IVC组)的18.00%、16.00%的发生率相比明显更低,两组比较差异有统计学意义(χ^(2)=7.814、4.000,P<0.05);此外,留置针组(IVC组)还出现4例非计划拔管,中等长度导管组还出现1例导管断裂/移位、1例非计划拔管、1例其他堵管。其他静脉血栓、CRBSI并发症两组均未发生。结论改良型中等长度导管较留置针用于神经内外科患者输注高渗药物有明显的优势,留置时间基本能满足患者的输液要求,且并发症发生率低,保证了患者治疗的有效性与安全性,值得临床推广应用。Objective To explore the clinical application advantages of the modified medium-length catheter in the infusion of hypertonic fluid.Methods 100 cases of patients with intravenous infusion of 20%mannitol and/or glycerol fructose in the hospital from March 2019 to April 2020 were simply random selected and divided into the indwelling needle group(intravenous catheter for single use,IVC)and the modified midline catheter group(midline catheters,MC)according to the random number table method,with 50 cases in each group.The incidence of complications during catheter indwelling was observed.Results The incidence of complications during catheter indwelling in the two groups was statistically compared.The results showed that the incidence of phlebitis and exudation in the medium-length catheter group(MC group)was 0.00%and 4.00%,respectively,which was significantly lower than that in the indwelling needle group(IVC group)(18.00%,16.00%),the difference between the two groups was statistically significant(χ^(2)=7.814,4.000,P<0.05).In addition,there were four unplanned extubations in the indwelling needle group(IVC group),one tube rupture/displacement,one unplanned extubation and one other tube blockage in the medium-length catheter group.Other venous thrombosis and CRBSI complications did not occur in both groups.Conclusion Compared with the indwelling needle used for the infusion of hypertonic drugs in neurosurgery patients,the improved medium-length catheter has obvious advantages,and the indwelling time can basically meet the patient's infusion requirements.In addition,the incidence of complications is low,which ensures the effectiveness and safety of patient treatment,which is worthy of clinical application.

关 键 词：改良型中等长度导管 留置针 高渗药物 静脉输液 并发症 

分 类 号：R5[医药卫生—内科学]